Attitudes of patients and family members towards implantable psychiatric medication

Mary E. Dankert, Colleen M. Brensinger, Kayla L. Metzger, Chunbo Li, Svetlinka G. Koleva, Andrea Mesén, Béatrice Laprade, Tjhin Wiguna, Changsu Han, Saeed Farooq, W. Emanuel Severus, Jocelyn G. Gayares, Jens M. Langosch, Xavier Lallart, Masaru Tateno, Adriana Mihai, Sudha R.N. Nair, Robert Belmaker, Janusz Rybakowski, Björn Owe-LarssonJohn M. Kane, Eve C. Johnstone, Donald J. MacIntyre, Sameer Malhotra, Ana González-Pinto, Fernando Mosquera, Suzann M. Babb, Ehsan Habib pour, Seyedeh Sedigheh Fatemi, Charles Swanson, Caleb Adler, Allan Young, Fumiko Hoeft, Kandiah Sivakumar, Petya D. Radoeva, Elise A. Lallart, Warren B. Bilker, Steven J. Siegel

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Introduction: Medication is a necessary part of treatment for severe psychiatric illnesses such as schizophrenia and nonadherence to prescribed medication is one of the most important public health issues in psychiatry today. The devastating consequences of nonadherence have motivated the development of novel therapeutic strategies, including a new long-term implantable medication delivery system. Methods: The current study assesses attitudes towards implantable medication in psychiatric patients and their family members. Patients included in the study had diagnoses of Schizophrenia, Schizoaffective Disorder, Mood or Anxiety related disorders. Results: 49.62% of patients and 74.47% of family members endorse support for implantable medication. Conclusions: This study demonstrates that implants may be an acceptable alternative to oral and injectable medication for a subset of psychiatric patients and their families.

Original languageEnglish
Pages (from-to)279-286
Number of pages8
JournalSchizophrenia Research
Issue number1-3
Publication statusPublished - Oct 2008


  • Adherence
  • Attitude
  • Drug implant
  • Family
  • Medication
  • Psychiatry
  • Schizophrenia


Dive into the research topics of 'Attitudes of patients and family members towards implantable psychiatric medication'. Together they form a unique fingerprint.

Cite this